Richard Wilde

Title: Richard Wilde: Innovator in Antibacterial Agents

Introduction

Richard Wilde is a notable inventor based in New Brunswick, NJ (US). He has made significant contributions to the field of antibacterial agents, particularly through his innovative research and development of compounds that inhibit bacterial RNA polymerase.

Latest Patents

Richard Wilde holds a patent for "Antibacterial agents: Nα-aroyl-N-aryl-phenylalaninamides." This invention provides compounds that exhibit activity as bacterial RNA polymerase inhibitors and antibacterial agents. The patent details compositions comprising these compounds and methods for their use. Specifically, it discloses phenylalanineamide and tyrosinamide compounds that demonstrate inhibitory activity toward RNA polymerase. The use of these compounds in the treatment or prevention of infections in mammals is also highlighted.

Career Highlights

Richard Wilde is affiliated with Rutgers, the State University of New Jersey, where he continues to advance his research in the field of antibacterial agents. His work has garnered attention for its potential applications in medical treatments.

Collaborations

Richard Wilde has collaborated with notable colleagues, including Richard H. Ebright and Yon W. Ebright, enhancing the impact of his research through shared expertise and knowledge.

Conclusion

Richard Wilde's contributions to the field of antibacterial agents exemplify the importance of innovation in combating bacterial infections. His patent and ongoing research at Rutgers University highlight his commitment to advancing medical science.